Third, given that at least some other SFRP family members can have both suppressive or activating roles on Wnt signaling activity depending on their individual expression levels [50], it cannot be excluded that upregulated SFRP4 might have a Wnt activator role specifically in ERG-negative cancers. This evidence concerns the gene ERG and cancer.